Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

Détails

ID Serval
serval:BIB_D70AE74A893E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Périodique
Oncology
Auteur(s)
Santa Cruz O., Tsoutsou P., Castella C., Khanfir K., Anchisi S., Bouayed S., Matzinger O., Ozsahin M.
ISSN
1423-0232 (Electronic)
ISSN-L
0030-2414
Statut éditorial
Publié
Date de publication
2018
Peer-reviewed
Oui
Volume
95
Numéro
2
Pages
61-68
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
To assess the feasibility and efficacy of intensity-modulated radiation implemented with helical tomotherapy image-guided with daily megavoltage computed tomography for head and neck cancer.
Between May 2010 and May 2013, 72 patients were treated with curative intent. The median age was 64 years, with 57% undergoing definitive and 43% postoperative radiotherapy. Primary tumour sites were oral cavity (21%), oropharynx (26%), hypopharynx (20%), larynx (22%), and others (11%). Staging included 4% stage I, 15% II, 26% III, 48% IVa, and 7% IVb. Radiotherapy was combined with chemotherapy in 64%. Primary endpoint was locoregional control, and secondary endpoints survival and toxicity.
Median follow-up was 20 months, with 11 locoregional recurrences. Three-year disease-free survival was 58% and overall survival 57%. In the multivariate analysis, age under 64 years, no extracapsular extension, postoperative radiotherapy, induction chemotherapy, and non-oral cavity tumour were significant favourable prognostic factors for disease-free-survival. The overall incidence of acute grade ≥3 toxicities were mucositis 32%, pain 11%, xerostomia 7%, dysphagia 53%, radiodermatitis 44%, and osteonecrosis 1%. Late grade ≥3 toxicities were fibrosis 6%, dysphagia 21%, fistula 1%, and skin necrosis 1%.
Intensity-modulated radiation with helical tomotherapy achieved respectable locoregional control and overall survival, with acceptable toxicity, in head and neck cancer patients.
Mots-clé
Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell/radiotherapy, Chemoradiotherapy/methods, Combined Modality Therapy, Disease-Free Survival, Female, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/radiotherapy, Humans, Male, Middle Aged, Radiotherapy Dosage, Radiotherapy, Conformal/adverse effects, Radiotherapy, Conformal/methods, Radiotherapy, Intensity-Modulated/adverse effects, Radiotherapy, Intensity-Modulated/methods, Retrospective Studies, Survival Rate, Head and neck cancer, Helical tomotherapy, Intensity-modulated RT toxicity
Pubmed
Web of science
Création de la notice
25/06/2018 9:06
Dernière modification de la notice
20/08/2019 15:56
Données d'usage